StocktoriaWerewolf Therapeutics, Inc. HOWL
Nasdaq · XNAS · stock · Pharmaceutical Preparations
Chart by TradingView
1/9
Piotroski F — financial health
—
Altman Z″ — distress risk
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Operating income | -$60.7M | -$73.6M | -$40.5M | -$56.1M | -$50.1M |
| Net income | -$60.8M | -$70.5M | -$37.4M | -$53.8M | -$50.0M |
| Operating cash flow | -$60.3M | -$56.2M | -$32.6M | -$40.6M | -$42.9M |
| Free cash flow | -$60.3M | -$56.4M | -$33.4M | -$44.2M | -$43.4M |
| Total assets | $69.4M | $126.9M | $174.8M | $160.2M | $179.2M |
| Total liabilities | $44.6M | $53.5M | $63.5M | $37.9M | $26.5M |
| Shareholders' equity | $24.8M | $73.4M | $111.4M | $122.3M | $152.8M |
| Ratios | |||||
| Return on assets | -87.6% | -55.6% | -21.4% | -33.6% | -27.9% |
| Return on equity | -245.2% | -96.1% | -33.6% | -44.0% | -32.7% |
| Debt / equity | 1.29× | 0.44× | 0.36× | — | — |
| Current ratio | 1.62 | 7.45 | 7.14 | 5.84 | 13.56 |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 516,218 | $429,803 |
Why these scores methodology →
Piotroski F-score: 1/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001785530 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.